Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
LLY
LLY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LLY News
Eli Lilly Increases Inventory for Weight Loss Pill Ahead of FDA Approval
2d ago
seekingalpha
Beijing May Prioritize Consumers in the Year of the Horse: Strategies to Consider.
6h ago
Barron's
Eli Lilly Acquires Orna Therapeutics to Enhance Drug Pipeline
16h ago
Fool
Market Rebounds as Eli Lilly Prepares for New Drug Launch
1d ago
CNBC
Novo Nordisk Addresses Drug Compounding Issues Amid Competition
1d ago
stocktwits
Casgevy Therapy Revenue Shows Significant Growth
1d ago
Benzinga
Eli Lilly Acquires Orna Therapeutics to Expand Drug Pipeline
1d ago
Fool
Walmart Becomes First Traditional Retailer to Achieve $1 Trillion Market Cap
1d ago
seekingalpha
Stock Index Futures Little Changed as Traders Await Key Retail Inflation Data
1d ago
seekingalpha
Pfizer's Dividend Yield Exceeds Market Average
2d ago
Fool
Pfizer's Long-Acting GLP-1 Weight Loss Drug Shows Promising Trial Results
2d ago
NASDAQ.COM
European Pharma Companies Look Ahead to 2026
2d ago
CNBC
Eli Lilly Stockpiles $1.5 Billion in Weight-Loss Drug Inventory
2d ago
Benzinga
Novo Nordisk Launches Wegovy in Vials to Compete
2d ago
Benzinga
McDonald's CEO Faces Challenge from GLP-1 Weight-Loss Drugs
2d ago
Yahoo Finance
Eli Lilly and Novo Nordisk's Weight Loss Drug Competition
3d ago
Fool
Show More News
